DHR vs GS: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and The Goldman Sachs Group, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
The Goldman Sachs Group, Inc. · Financial Services
$923.29
+25.9% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
GS |
| Current Price |
$221.12 |
$923.29 |
| Fair Value Estimate |
$286.52 |
$1,162.79 |
| Upside to Fair Value |
+29.6%
|
+25.9%
|
| Market Cap |
$155.4B |
$272.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
26.3x
|
| Price / Sales |
6.2x
|
2.3x
|
| Price / FCF |
28.5x
|
—
|
| Revenue Growth YoY |
+5.5%
|
+22.9%
|
| Gross Margin |
58.5%
|
57.3%
|
| Operating Margin |
20.4%
|
24.8%
|
| Return on Equity |
7.7%
|
17.0%
|
| Dividend Yield |
0.65% |
1.95% |
| FCF Yield |
3.51%
|
—
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Goldman Sachs is a global financial services firm operating four divisions: Investment Banking, Global Markets, Asset Management, and Consumer & Wealth Management, with 46,200 full-time employees and a market cap of $272.38 billion at a current price of $923.29. The business quality is high because of its leading franchise in advisory, underwriting, and trading, evidenced by a 17.0% ROE, a 57.3% …
Accumulation Zones
| Metric |
DHR |
GS |
| Zone Low |
$214.89 |
$872.09 |
| Zone High |
$243.54 |
$988.37 |
| In Buy Zone? |
Yes
|
Yes
|